A61K36/532

Solid drink for regulating phlegm-dampness constitution and processing method thereof
10406195 · 2019-09-10 ·

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, fructus perillae 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, fructus amomi 4-15 parts, malt 26-50 parts, agastache rugosa 14-33 parts, kelp 24-51 parts, semen coicis 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts.

Composition for the prevention or treatment of respiratory diseases caused by fine dust comprising <i>Agastache rugosa </i>and licorice extract

The Agastache rugosa and licorice complex mixture of the present invention has the synergy effects for the efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD11b+ cell ratio reduction, and suppressing sputum production through inhibition of MUC5AC activity and therefore it can be widely utilized as a composition for the prevention or treatment of respiratory diseases.

Composition for the prevention or treatment of respiratory diseases caused by fine dust comprising <i>Agastache rugosa </i>and licorice extract

The Agastache rugosa and licorice complex mixture of the present invention has the synergy effects for the efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD11b+ cell ratio reduction, and suppressing sputum production through inhibition of MUC5AC activity and therefore it can be widely utilized as a composition for the prevention or treatment of respiratory diseases.

Composition for the prevention or treatment of respiratory diseases caused by fine dust comprising <i>Agastache rugosa </i>and licorice extract

The Agastache rugosa and licorice complex mixture of the present invention has the synergy effects for the efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD11b+ cell ratio reduction, and suppressing sputum production through inhibition of MUC5AC activity and therefore it can be widely utilized as a composition for the prevention or treatment of respiratory diseases.

Solid Drink for Regulating Phlegm-dampness Constitution and Processing Method thereof
20190160137 · 2019-05-30 ·

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, fructus perillae 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, fructus amomi 4-15 parts, malt 26-50 parts, agastache rugosa 14-33 parts, kelp 24-51 parts, semen coicis 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts.

Solid Drink for Regulating Phlegm-dampness Constitution and Processing Method thereof
20190160137 · 2019-05-30 ·

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, fructus perillae 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, fructus amomi 4-15 parts, malt 26-50 parts, agastache rugosa 14-33 parts, kelp 24-51 parts, semen coicis 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts.

Solid Drink for Regulating Phlegm-dampness Constitution and Processing Method thereof
20190160137 · 2019-05-30 ·

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, fructus perillae 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, fructus amomi 4-15 parts, malt 26-50 parts, agastache rugosa 14-33 parts, kelp 24-51 parts, semen coicis 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts.

Fructus forsythiae and radix astragali compound preparation, and preparation method therefor and use thereof

A Fructus Forsythiae and Radix Astragali compound preparation, and a preparation method therefor and a use thereof is provided. Traditional Chinese medicine formulation components consist of the following raw materials or raw material extracts in parts by mass: 9-11 parts of Flos Lonicerae, 9-11 parts of Fructus Forsythiae, 9-11 parts of Radix Scutellariae, 9-11 parts of Herba Artemisiae Annuae, 9-11 parts of Radix Astragali, 9-11 parts of stir-fried Rhizoma Atractylodis Macrocephalae, 9-11 parts of Herba Pogostemonis, 5-7 parts of Radix Saposhnikoviae, 9-11 parts of Radix Ophiopogonis, and 5-7 parts of Radix Glycyrrhizae. The components can be made into an oral liquid, a granule, a dissolved medicine, or a tablet. Further disclosed is a use of the Fructus Forsythiae and Radix Astragali compound preparation in preparation of medicines for preventing and/or treating a viral influenza disease.

Fructus forsythiae and radix astragali compound preparation, and preparation method therefor and use thereof

A Fructus Forsythiae and Radix Astragali compound preparation, and a preparation method therefor and a use thereof is provided. Traditional Chinese medicine formulation components consist of the following raw materials or raw material extracts in parts by mass: 9-11 parts of Flos Lonicerae, 9-11 parts of Fructus Forsythiae, 9-11 parts of Radix Scutellariae, 9-11 parts of Herba Artemisiae Annuae, 9-11 parts of Radix Astragali, 9-11 parts of stir-fried Rhizoma Atractylodis Macrocephalae, 9-11 parts of Herba Pogostemonis, 5-7 parts of Radix Saposhnikoviae, 9-11 parts of Radix Ophiopogonis, and 5-7 parts of Radix Glycyrrhizae. The components can be made into an oral liquid, a granule, a dissolved medicine, or a tablet. Further disclosed is a use of the Fructus Forsythiae and Radix Astragali compound preparation in preparation of medicines for preventing and/or treating a viral influenza disease.

Combined herbal and pharmaceutical composition and method
10086026 · 2018-10-02 ·

An herbal combination composition can include, herbal extracts, including combinations of: Hyssopus officinalis, Zingiber officinale, Viola odorata, Ziziphus jujuba, Chamomile, and Ocimum tenuiflorum; pharmaceutical compositions, including combinations of: dextromethorphan, guaifenesin, acetaminophen, phenylephrine, diphenhydramine; polyethylene glycol; propylene glycol; poloxamer 407; ethylenediaminetetraacetic acid; methyl paraben; potassium sorbate; propyl paraben; xanthan gum; citric acid; anhydrous citric; and purified acetate buffered water. Also disclosed is a method for manufacture of an herbal combination composition, including dissolving herbal extracts, adding poloxamer, adding pharmaceutical compositions, adding acetate buffer, adding xanthan gum gel, adding acetate buffer.